Epidemiology and antimicrobial resistance trends of invasive bacterial pathogens in the Gambia: a retrospective analysis, 2019-2024 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Trends in Antimicrobial Resistance and Epidemiology of Invasive Bacterial Pathogens in The Gambia: A Retrospective Study from 2019 to 2024

  • By

  • Abdulrahman Yakubu Mohammed

  • Mustapha Dibbasey

  • Buntung Ceesay

  • Morrow Minteh

  • Solomon E. Umukoro

  • Ousman Secka

  • Abdoulie Bojang

  • September 26, 2026

Share

  • 1

    Invasive bacterial pathogens remain an important cause of morbidity and mortality, particularly in sub-Saharan Africa, and continue to pose public health challenges in The Gambia.

  • 2

    In this study, Staphylococcus aureus was the most common invasive bacterial pathogen, followed by Escherichia coli, Streptococcus pyogenes, Streptococcus pneumoniae, and Klebsiella pneumoniae.

  • 3

    Previous vaccine introductions have shifted the epidemiology of invasive bacterial disease in The Gambia, while S. aureus and E. coli have emerged as leading causes.

  • 4

    Antimicrobial resistance remains a major concern, with high resistance observed to several commonly used antibiotics among invasive bacterial pathogens.

  • 5

    This study analyzes invasive bacterial pathogen epidemiology and antimicrobial resistance trends from 2019 through 2024 to support surveillance, empirical treatment, and antimicrobial stewardship.

Original Source(s)

Epidemiology and antimicrobial resistance trends of invasive bacterial pathogens in the Gambia: a retrospective analysis, 2019-2024

  • by Abdulrahman Yakubu Mohammed, Mustapha Dibbasey, Buntung Ceesay, Morrow Minteh, Solomon E. Umukoro, Ousman Secka, Abdoulie Bojang

  • September 26, 2026

Related Content

Molecular based diagnostic testing for urinary tract infections: the results remain unclear

Lytic bacteriophages active in urine against multidrug-resistant clinically derived Klebsiella pneumoniae causing urinary tract infection

Vancomycin dosing in critically ill patients receiving renal replacement therapy: a critical appraisal of the toxicity threshold and external validation